A股異動 | 長亮科技飆升近15% 第二季度單季淨利潤同比增585.45%
格隆匯8月5日丨長亮科技飆升近15%,報11.11元,總市值80億元。長亮科技2022中報顯示,公司主營收入6.82億元,同比上升38.36%;歸母淨利潤678.1萬元,同比下降20.39%;扣非淨利潤316.37萬元,同比上升253.81%;其中2022年第二季度,公司單季度主營收入4.05億元,同比上升25.58%;單季度歸母淨利潤1664.8萬元,同比上升585.45%;單季度扣非淨利潤1478.48萬元,同比上升366.79%;負債率41.28%,投資收益-85.24萬元,財務費用1161.15萬元,毛利率39.51%。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.